Skip to content
Use caution Drug recall · FDA · Published April 7, 2015

Apotex Recalls Olanzapine Tablets Due to Subpotency

Apotex recalls 5,352 bottles of 20 mg Olanzapine orally disintegrating tablets due to subpotent drug levels. Check your lot number KL0664.

🇺🇸 FDA recall #D-1081-2015DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling one lot of Olanzapine, Orally Disintegrating Tablets, 20 mg, in 30-count bottles because the drug may be subpotent. The affected product was distributed nationwide and manufactured in Toronto, Ontario, Canada. No specific remedy or return instructions are provided in this record. Read more at govinfonow.com/recall/44810-apotex-inc-recalls-olanzapine-orally-disintegrating-tablets-20-mg-30.

Source Summary by GovInfoNow · govinfonow.com/recall/44810-apotex-inc-recalls-olanzapine-orally-disintegrating-tablets-20-mg-30 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1081-2015

Cite this page

“Apotex Recalls Olanzapine Tablets Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44810-apotex-inc-recalls-olanzapine-orally-disintegrating-tablets-20-mg-30. Based on FDA recall #D-1081-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1081-2015%22&limit=1).

The FDA announced on April 7, 2015, that Apotex Inc. voluntarily recalled Olanzapine Orally Disintegrating Tablets due to subpotency risks. The recall affects 5,352 bottles distributed nationwide.

How to tell if you have it

  • Brand: Apotex
  • Product: Olanzapine Orally Disintegrating Tablets
  • Strength/Size: 20 mg, 30-count bottle
  • Lot Code: KL0664
  • Expiration Date: 04/15

The hazard

The recalled Olanzapine tablets are subpotent drugs. The FDA classification is Class III.

Context

GovInfoNow's records show Apotex Inc. has had 19 other recalls since April 30, 2012. Recent similar recalls include an Apotex Metformin Tablets recall on May 27, 2020, and an Apotex Atorvastatin 40mg Tablets recall on October 22, 2019. Other recent recalls of similar products include an Apotex Paroxetine 37.5mg recall on September 23, 2026, and an Unichem busPIRone 5mg Tablets recall on April 13, 2026.

How to tell if you have this one

Check if you have a 30-count bottle of Olanzapine, Orally Disintegrating Tablets, 20 mg, manufactured by Apotex Inc. Specifically look for Lot # KL0664 with an expiration date of 04/15.

  • Brand
    Apotex
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantity
D-1079-2015Olanzapine, Orally Disintegrating Tablets, 5 mg, a) 30-count bottle (NDC 60505-3275-03), b) 100-count blister (NDC 60505-3275-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9; Lot #: a) KL0655, Exp 04/15; KY2374, Exp 05/16; b) KL0656, Exp 04/15; KY2371, Exp 05/1623,274 bottles/ blister cartons
D-1080-2015Olanzapine, Orally Disintegrating Tablets, 10 mg, a) 30-count bottle (NDC 60505-3276-03), b) 100-count blister (NDC 60505-3276-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9; Lot #: a) KY2389, Exp 05/16; b) KY2388, Exp 05/166,467 bottles/ blister cartons
D-1081-2015Olanzapine, Orally Disintegrating Tablets, 20 mg, 30-count bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9; Lot # KL0664, Exp 04/155,352 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your bottle matches the recalled lot number KL0664 and expiration date 04/15.

  2. Contact Your Pharmacist

    Speak with your pharmacist or healthcare provider to determine how to proceed with replacement or alternative treatment.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Apr 7, 201512. FDA classified it Class III: May 14, 201523. Published in FDA’s Enforcement Report: May 20, 201534. FDA terminated the recall: Apr 7, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1081-2015 (April 7, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1081-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA